Intermediate for Idelalisib. Idelalisib (trade name Zydelig) is a phosphoinositide 3-kinase inhibitor for the treatment of certain hematological malignancies. Idelalisib has been approved by the U.S Food and Drug Administration on July 23, 2014.


Product Name:                  2-Amino-6-fluoro-N-phenylbenzamide

Synonyms:                         N/A

CAS Number:                     1417456-04-2

Molecular Weight:            230.2411

Molecular Formula:          C13H11FN2O

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               FC1=CC=CC(N)=C1C(NC2=CC=CC=C2)=O


  • $207.00
  • Ex Tax: $207.00

Available Options